| Aktie | Ticker | Breite | GCS | 2026/Q1 | 2025/Q4 | 2025/Q3 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | ||||
| 533.044.013 $ | +255.601.467 $ | +84,5 % | 13 | 255.233.506 $ | +97.226.472 $ | +111,8 % | 8 | 165.517.534 $ | +54.921.961 $ | +74,1 % | 4 | ||||
| Tango Therapeutics, Inc. | TNGX | → 0 | Neutral | 227.530.501 $ | +131.167.201 $ | +136,1 % | 1 | 96.363.300 $ | +14.282.826 $ | +17,4 % | 1 | 82.080.474 $ | +32.050.471 $ | +64,1 % | 1 |
| Kodiak Sciences Inc. | KOD | → 0 | Schwach | 51.881.320 $ | +20.118.760 $ | +63,3 % | 1 | 31.762.560 $ | +19.485.060 $ | +158,7 % | 1 | ||||
| Revolution Medicines, Inc. | RVMD | → 0 | Schwach | 48.625.000 $ | +16.765.000 $ | +52,6 % | 1 | 31.860.000 $ | +13.180.000 $ | +70,6 % | 1 | 18.680.000 $ | -10.493.624 $ | -36,0 % | 1 |
| uniQure N.V. | QURE | → 0 | Schwach | 46.696.000 $ | +34.156.970 $ | +272,4 % | 1 | ||||||||
| Kymera Therapeutics, Inc. | KYMR | → 0 | Schwach | 27.410.739 $ | +1.803.468 $ | +7,0 % | 1 | 25.607.271 $ | +7.546.211 $ | +41,8 % | 1 | 18.061.060 $ | -791.856 $ | -4,2 % | 1 |
| Celcuity Inc. | CELC | → 0 | Schwach | 25.681.500 $ | +3.240.000 $ | +14,4 % | 1 | 22.441.500 $ | +17.995.500 $ | +404,8 % | 1 | ||||
| Surrozen, Inc./DE | SRZN | → 0 | Neutral | 22.322.843 $ | +12.917.853 $ | +137,4 % | 1 | ||||||||
| Abivax S.A. | ABVX | → 0 | Schwach | 22.270.000 $ | +5.413.125 $ | +32,1 % | 1 | 16.856.875 $ | +6.668.875 $ | +65,5 % | 1 | ||||
| Terns Pharmaceuticals, Inc. | TERN | → 0 | 19.770.000 $ | +4.620.000 $ | +30,5 % | 1 | 15.150.000 $ | +15.150.000 $ | 1 | ||||||
| Vaxcyte, Inc. | PCVX | → 0 | Neutral | 18.885.750 $ | +18.885.750 $ | 1 | |||||||||
| CAPRICOR THERAPEUTICS, INC. | CAPR | → 0 | Schwach | 17.936.000 $ | +8.556.500 $ | +91,2 % | 1 | ||||||||
| Protagonist Therapeutics, Inc | PTGX | → 0 | Neutral | 17.918.000 $ | +3.070.200 $ | +20,7 % | 1 | ||||||||
| Vir Biotechnology, Inc. | VIR | → 0 | Neutral | 16.719.360 $ | +12.950.610 $ | +343,6 % | 1 | ||||||||
| Corvus Pharmaceuticals, Inc. | CRVS | → 0 | Neutral | 16.093.000 $ | +16.093.000 $ | 1 | |||||||||
| PTC THERAPEUTICS, INC. | PTCT | → 0 | Neutral | 15.192.000 $ | +2.918.000 $ | +23,8 % | 1 | ||||||||
| 533.044.013 $ | +255.601.467 $ | +84,5 % | 13 | 255.233.506 $ | +97.226.472 $ | +111,8 % | 8 | 165.517.534 $ | +54.921.961 $ | +74,1 % | 4 | ||||